Brief: Neurosense CEO Provides Q2 2023 Update

Neurosense Therapeutics

06/07/2023 13:33

July 6 (Reuters) - Neurosense Therapeutics Ltd  NRSN.O :
    * NEUROSENSE CEO PROVIDES Q2 2023 UPDATE
    * NEUROSENSE THERAPEUTICS LTD: IS FUNDED NOW THROUGH
MID-2024
    * NEUROSENSE THERAPEUTICS LTD: WITH ENROLLMENT OF PARADIGM
COMPLETED, WE ARE ON TRACK TO REPORT TOPLINE RESULTS BEFORE END
OF 2023

Source text for Eikon:  ID:nPn8l4ct1a 
Further company coverage:  NRSN.O 

 ((reuters.briefs@thomsonreuters.com;))